Expressive Wealth LLC Invests $641,000 in Cardinal Health, Inc. $CAH

Expressive Wealth LLC purchased a new position in shares of Cardinal Health, Inc. (NYSE:CAH) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 3,118 shares of the company’s stock, valued at approximately $641,000.

Several other institutional investors and hedge funds have also modified their holdings of CAH. Aventura Private Wealth LLC purchased a new position in shares of Cardinal Health during the 4th quarter worth $25,000. Jones Financial Companies Lllp boosted its stake in shares of Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after acquiring an additional 14,034 shares during the last quarter. JPL Wealth Management LLC purchased a new position in shares of Cardinal Health during the 3rd quarter worth $31,000. Turning Point Benefit Group Inc. purchased a new position in shares of Cardinal Health during the 3rd quarter worth $31,000. Finally, Cape Investment Advisory Inc. boosted its stake in shares of Cardinal Health by 61.1% during the 3rd quarter. Cape Investment Advisory Inc. now owns 211 shares of the company’s stock worth $33,000 after acquiring an additional 80 shares during the last quarter. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Performance

CAH opened at $200.94 on Wednesday. Cardinal Health, Inc. has a fifty-two week low of $137.75 and a fifty-two week high of $233.60. The firm’s fifty day moving average is $204.51 and its 200 day moving average is $208.89. The stock has a market cap of $47.06 billion, a price-to-earnings ratio of 30.72, a price-to-earnings-growth ratio of 1.19 and a beta of 0.53.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. The company had revenue of $60.94 billion for the quarter, compared to analysts’ expectations of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. Cardinal Health’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, equities research analysts predict that Cardinal Health, Inc. will post 10.76 earnings per share for the current year.

Cardinal Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be issued a $0.5158 dividend. The ex-dividend date is Wednesday, July 1st. This represents a $2.06 dividend on an annualized basis and a yield of 1.0%. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s payout ratio is presently 31.19%.

Analysts Set New Price Targets

Several brokerages have recently weighed in on CAH. Evercore dropped their price target on shares of Cardinal Health from $260.00 to $240.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 8th. Citigroup lowered their target price on shares of Cardinal Health from $249.00 to $245.00 and set a “buy” rating on the stock in a research note on Friday, May 1st. Leerink Partners restated an “outperform” rating and set a $275.00 target price on shares of Cardinal Health in a research note on Monday, March 9th. Wall Street Zen upgraded shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, May 2nd. Finally, Barclays lifted their target price on shares of Cardinal Health from $243.00 to $258.00 and gave the company an “overweight” rating in a research note on Tuesday, February 24th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, Cardinal Health has a consensus rating of “Moderate Buy” and a consensus target price of $241.80.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.